Topics at «Genetics — Moving to the Center of Healthcare» include the role of genomic testing in guiding cancer treatment, approaches to helping families that are coping with genetic diagnoses, and interpretation and use of
genomic sequencing results in the newborn population.
255/3: 15 Communication and management of
genomic sequencing results by non-geneticist physicians.
Competitors have been tasked with discovering the unknown genetic basis of the disorders faced by three pediatric patients and, in the process, create best practices for interpreting and presenting
genomic sequence results to patients and their families and physicians in meaningful ways that can help guide healthcare decisions.
Not exact matches
Scientists at the University of Maryland have developed a new, web - based tool that enables researchers to quickly and easily visualize and compare large amounts of
genomic information
resulting from high - throughput
sequencing experiments.
Without this approach, the
results of
genomic sequencing would have been swamped with DNA from normal cells, making it difficult to detect cancer - linked DNA errors, Papp says.
They conducted complete
genomic sequencing of all genes implicated in breast cancer on DNA samples from breast cancer patients who had normal BRCA1 and BRCA2 commercial test
results.
However,
genomic sequencing, combined with epidemiological investigation, indicated that the cases did not represent a re-introduction from a neighboring country, but instead were the
result of virus transmission from a «persistently infected» source within Liberia — meaning, for example, a disease survivor who continued to carry the virus for several months.
The
results, published in the journal Nature Biotechnology, reveal that the small, accessible and cost effective technology could revolutionize
genomic sequencing.
After selection, the mutant CK123 (bottom) was generated and the
genomic segment between primers # 8134 and # 8135 was PCR amplified and the
resulting amplicon was
sequenced from both directions using nested
sequencing primers # 8136 and # 8137.
The advent of accessible and relatively inexpensive high - throughput
sequencing technology has
resulted in extensive
sequencing of whole human genomes or exomes in a research setting and seems likely to lead to an explosion of
genomic sequencing in a clinical context.
As a
result, we're seeing exome and genome
sequencing studies published all over the place, not just in genetics /
genomics journals but also many that focus on specific tissues (e.g. blood) or diseases (e.g. cancer, metabolic diseases, vision disorders, you name it).
Sparked from the efforts of the T2D - GENES Consortium (Type 2 Diabetes Genetic Exploration by Next - generation
sequencing in multi-Ethnic Samples; T2D - GENES) to aggregate and share
results from large - scale T2D
sequence and genotype datasets, the prototype T2D KP was built with seed funding from the NIDDK via the T2D - GENES Consortium and the Slim Initiative for
Genomic Medicine in the Americas for T2D (SIGMA T2D).
We have generated rich
genomic datasets for the scientific community, including an expansive atlas of genetic associations with metabolites, whole - genome
sequence and phenotype data for population cohorts in the UK10K project, as well as bioinformatic resources to facilitate the retrieval of information, including a metabolite network, a database of genotype - metabolite associations with our colleagues at the HelmHoltz institute, and a genome browser of UK10K association
results.
The
resulting datasets of regulatory
genomic sequence will provide a valuable resource in determining how non-coding DNA
sequence variation may impact an individual's capacity to drive appropriate gene expression.
Building the fourth generation of GATK (GATK4) on Cloudera Enterprise and utilizing the Spark distributed computing framework to speed research, the Broad Institute is facilitating better understanding of
genomic sequencing,
resulting in faster data exploration and ultimately empowering better clinical decisions.
It is also recommended that the current voluntary restriction on insurers» ability to ask for predictive genetic test
results should be renewed, in the light of public concerns over
genomic data disclosure to insurers and the risk that this might
result in many «refusing their consent to receive additional findings from whole genome
sequencing».
Genomic Inheritances: Disclosing Individual Research
Results From Whole - Exome
Sequencing to Deceased Participants» Relatives The American Journal of Bioethics, 12 (10), 1 - 8 DOI: 10.1080 / 15265161.2012.699138
Hits with a better match in the GenBank nonredundant nucleotide database (NT), corresponding predominantly to human
genomic background
sequences resulting from misannotations in GenBank, were excluded from the analysis.
As a
result, we will soon be able to ask new biological questions — about evolution, minimal genome
sequences that support viability under different conditions, and the requirement of specific
genomic features such as repeats and introns.
Based on these fine mapping
results, the THBS2 gene (59.45 — 59.47 Mb) and neighboring (58.8 — 59.0 Mb) SMOC - 2 gene (exon 1 from SMOC - 2 was unable to be cloned or
sequenced) were
sequenced in
genomic DNA and cDNA from a Boxer (brachycephalic) and a Dalmatian (non-brachycephalic) dog.